GPC2 and neuroblastoma: In detail, GPC2-redirected immunotoxins suppressed neuroblastoma growth, and consistent with this finding, VHH-based GPC2-redicted CAR-Ts also demonstrated significant antitumor activity against IMR5 cells with high levels of GPC2 expression [87].